retatrutide triple hormone receptor agonist Unapproved weight loss drug causes extreme side effects retatrutide - Diabetes In Control

A tiny 0.25mg dose would be a very manageable 0.1mL (10 units)

What are the most common side effects

Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis

Injection site infections are rare but entirely preventable

Its completely normal to feel uncertain about starting a new medication, especially when it comes with potential side effects

GLP-1 receptor agonists in PD Approved treatments for PD target dopaminergic neurotransmission, with levodopa representing the mainstay of treatments augmenting dopamine production and alleviating motor symptoms [6]